Expect Buzz About Vowst, a New Oral Fecal Microbiota Product

August 2023

Rx Vowst will be the first ORAL fecal microbiota product that’s FDA-approved for preventing C. diff recurrence in adults.

It comes on the heels of FDA approval of Rebyota...a fecal microbiota enema. Other fecal transplant products are investigational.

Any of these options may seem unappealing, but “transplanting” fecal microbiota can help restore a healthy GI flora.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote